Fischer Medical Ventures Complete Financial Statements
In FY2026, Fischer Medical Ventures (FISCHER) reported revenue ₹99 Cr, net profit ₹-7 Cr and EPS ₹-0.11, with a net profit margin of -7.1% and ROE of -1.8%. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see FISCHER screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
FISCHER Revenue, Net Profit & EBITDA — Year-on-Year Growth
FISCHER YoY (Mar 2025 vs Mar 2026) — revenue +102.0%, net profit -800.0%, EBITDA -33.3%, expenses +106.4%. Analyse FISCHER shareholder distribution to track promoter, FII and institutional holdings.
FISCHER Income Statement — Revenue, EBITDA & Net Profit
Fischer Medical Ventures revenue ₹99 Cr, EBITDA ₹2 Cr, net profit ₹-7 Cr, EPS ₹-0.11 (2026) — net profit margin -7.1%. Examine FISCHER Q4 results for recent quarterly revenue, profit and EPS trends.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Jun 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99 | 89 | 49 | 31 | 102 | 40 | 21 | 11 | 12 | 0 | 0 | 0 |
| Expenses | 97 | 70 | 47 | 19 | 80 | 39 | 18 | 10 | 11 | 0 | 0 | 1 |
| EBITDA | 2 | 19 | 3 | 12 | 23 | 1 | 3 | 1 | 1 | 0 | 0 | -1 |
| Operating Profit Margin % | 1.00% | 19.00% | 5.00% | 18.00% | 21.00% | 1.00% | 12.00% | -3.00% | 3.00% | 0.00% | 0.00% | -347.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 4 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | 17 | 2 | 10 | 21 | 0 | 3 | 0 | 0 | 0 | 0 | -1 |
| Tax | 5 | 3 | 1 | 5 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -7 | 14 | 1 | 5 | 19 | 0 | 3 | 0 | 0 | 0 | 0 | -1 |
| Earnings Per Share (₹) | -0.11 | 0.22 | -0.05 | 0.77 | 0.30 | 0.05 | 0.48 | 0.65 | -0.05 | 0.00 | 0.00 | 0.00 |
FISCHER Balance Sheet — Assets, Liabilities & Shareholders' Equity
FISCHER total assets ₹672 Cr, total equity ₹385 Cr, total liabilities ₹ Cr (2026) — ROE -1.8%.
| Particulars | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 672 | 457 | 86 | 0 |
| Current Assets | 414 | 365 | 70 | 0 |
| Fixed Assets | 29 | 24 | 15 | 0 |
| Capital Work in Progress | 3 | 1 | 0 | 0 |
| Investments | 13 | 11 | 1 | 0 |
| Other Assets | 0 | 422 | 70 | 0 |
| LIABILITIES | ||||
| Total Liabilities | ||||
| Current Liabilities | 27 | 18 | 1 | 1 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 385 | 338 | 81 | 0 |
| Share Capital | 65 | 64 | 54 | 0 |
| Reserves & Surplus | 319 | 244 | 27 | 0 |
FISCHER Cash Flow Statement — Operating, Investing & Financing
Fischer Medical Ventures operating cash flow ₹-87 Cr, investing ₹-125 Cr, financing ₹315 Cr, net cash flow ₹103 Cr (2025).
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | -87 | -7 |
| Investing Activities | -125 | -29 |
| Financing Activities | 315 | 37 |
| Net Cash Flow | 103 | 1 |